Accès ouvert
2025
article
OpenAlex
Mandip S. Singh, Umar Farooq, Sajad Ahmed Gani
Central nervous system (CNS) disorders remain among the most challenging conditions to treat due to the restrictive nature of the blood-brain barrier (BBB), which significantly limits the delivery of therapeutic agents to the brain. Traditional systemic drug delivery methods often result in …
in
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Arvind Bagde, Keb M. Mosley-Kellum, Sungsool Wi, Nisarg Modi et autres
us
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Aakash Nathani, Islauddin Khan, Matheus Hikaru Tanimoto, Jennyfer Andrea Aldana Mejía et autres
Background/Aim: Low selectivity and high frequency of side-effects are the major problems of currently used chemotherapeutics. Among natural compounds, the polyprenylated acylphloroglucinol, guttiferone E, isolated from Brazilian red propolis, has attracted attention due to its marked anticancer properties and was evaluated here …
us, br
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Aakash Nathani, Mounika Aare, Li Jun Sun, Arvind Bagde et autres
This study investigates the use of camel milk-derived exosomes (CMEs) as carriers for ARV-825, an anticancer agent targeting bromodomain-containing protein 4 (BRD4), in oral chemotherapy. CMEs were isolated and characterized, and ARV-825-loaded CME formulations were prepared and evaluated through various in vitro …
us
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Arvind Bagde, Keb M. Mosley-Kellum, Oluwaseyi Salau, Satyanarayan R. S. Dev et autres
Transdermal system (TDS) patches, a long-standing product in the market, still grapple with issues of secure skin adherence, efficacy, and safety. Hence, there is a pressing need to study factors affecting TDS patch adhesion on skin-mimetic substrates to enhance reliability and reduce …
Accès ouvert
2024
erratum
OpenAlex
Keb M. Mosley-Kellum, Arvind Bagde, Shawn D. Spencer, Satyanarayan R. S. Dev et autres
us
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Islauddin Khan, Sukhmandeep Kaur, Arun K. Rishi, Breana Boire et autres
BACKGROUND: In this study, we investigated in detail the role of cannabidiol (CBD), beta-caryophyllene (BC), or their combinations in diabetic peripheral neuropathy (DN). The key factors that contribute to DN include mitochondrial dysfunction, inflammation, and oxidative stress. METHODS: Briefly, streptozotocin (STZ) (55 …
us
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Mounika Aare, Arvind Bagde, Aakash Nathani, Arun K. Rishi et autres
us
(code pays fourni par la source)
Accès ouvert
2024
preprint
OpenAlex
Arvind Bagde, Keb M. Mosley-Kellum, Oluwaseyi Salau, Satyanarayan R. S. Dev et autres
us
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Arvind Bagde, Keb M. Mosley-Kellum, Shawn D. Spencer, Mandip S. Singh
OBJECTIVE: The objective of the present study was to enhance the bioavailability of cannabidiol (CBD) using 3D Digital Light Processing (DLP)-printed microneedle (MN) transdermal drug delivery system. METHODS: CBD MN patch was fabricated and optimized using 3D DLP printing using CBD (8% …
us
(code pays fourni par la source)
2024
conference-abstract
OpenAlex
Mounika Aare, Islauddin Khan, Aakash Nathani, Breana Boirie et autres
Abstract Combination therapy, a treatment modality that studies the effect of two or more drugs is the most common strategy used to overcome drug resistance in cancer. Cannabinoids have been proven to be potential anticancer agents. Terpenes have also been demonstrated to …
us
(code pays fourni par la source)
2024
conference-abstract
OpenAlex
Aakash Nathani, Mounika Aare, Li Jun Sun, Yan Li et autres
Abstract DIPGs (diffuse intrinsic pontine gliomas) are a particularly aggressive and malignant type of pediatric brain tumor. Given the tumor's location, surgery has a restricted role, and it is insensitive to most chemotherapies. Although fractionated radiation is the standard of therapy for …
us
(code pays fourni par la source)